Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04318223
Title Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Consorzio Oncotech

Her2-receptor negative breast cancer



Age Groups: adult
Covered Countries ITA

No variant requirements are available.